CHM-029
Asset
Inhibits menin to overcome resistance in acute myeloid leukemia
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Epigenetic regulation of gene expression
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Acute myeloid leukemia
Phase 1, globenewswire.com, 7 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Evidence for its targets2
- Competitors12
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.